Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J Marsh

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cancer Letters|May 29, 2012
Gonadotropin signalling in epithelial ovarian cancerInga Mertens-Walker, Robert C Baxter, Deborah J Marsh
Endocrine-Related Cancer|June 4, 2014
Histone H2B monoubiquitination: roles to play in human malignancyAlexander J Cole, Roderick Clifton-Bligh, Deborah J Marsh
Frontiers in Oncology|June 28, 2014
Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targetsDeborah J Marsh, Jaynish S Shah, Alexander J Cole
Molecular and Cellular Endocrinology|June 1, 2021
Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signalingChristine Bolitho, Michelle Moscova, Robert C Baxter, et al.
Endocrine-Related Cancer|March 11, 2010
Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}Inga Mertens-Walker, Christine Bolitho, Robert C Baxter, et al.
Endocrine-Related Cancer|August 13, 2010
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptorChristine Bolitho, Michael A Hahn, Robert C Baxter, et al.
Scientific Reports|September 22, 2023
A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational modelsMarilisa Cortesi, Dongli Liu, Christine Yee, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Genetic testing in pheochromocytoma- and paraganglioma-associated syndromesDiana E Benn, Anne Louise Richardson, Deborah J Marsh, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromesDeborah J Marsh, Michael A Hahn, Viive M Howell, et al.
International Journal of Molecular Sciences|August 27, 2021
PARP Inhibitors Display Differential Efficacy in Models of <i>BRCA</i> Mutant High-Grade Serous Ovarian CancerKristie-Ann Dickson, Tao Xie, Christian Evenhuis, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cancer Letters|May 29, 2012
Gonadotropin signalling in epithelial ovarian cancerInga Mertens-Walker, Robert C Baxter, Deborah J Marsh
Endocrine-Related Cancer|June 4, 2014
Histone H2B monoubiquitination: roles to play in human malignancyAlexander J Cole, Roderick Clifton-Bligh, Deborah J Marsh
Frontiers in Oncology|June 28, 2014
Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targetsDeborah J Marsh, Jaynish S Shah, Alexander J Cole
Molecular and Cellular Endocrinology|June 1, 2021
Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signalingChristine Bolitho, Michelle Moscova, Robert C Baxter, et al.
Endocrine-Related Cancer|March 11, 2010
Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}Inga Mertens-Walker, Christine Bolitho, Robert C Baxter, et al.
Endocrine-Related Cancer|August 13, 2010
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptorChristine Bolitho, Michael A Hahn, Robert C Baxter, et al.
Scientific Reports|September 22, 2023
A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational modelsMarilisa Cortesi, Dongli Liu, Christine Yee, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Genetic testing in pheochromocytoma- and paraganglioma-associated syndromesDiana E Benn, Anne Louise Richardson, Deborah J Marsh, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromesDeborah J Marsh, Michael A Hahn, Viive M Howell, et al.
International Journal of Molecular Sciences|August 27, 2021
PARP Inhibitors Display Differential Efficacy in Models of <i>BRCA</i> Mutant High-Grade Serous Ovarian CancerKristie-Ann Dickson, Tao Xie, Christian Evenhuis, et al.
Pageof 7